Cell Manufacturing– tag –
-
Allogeneic CAR-T Manufacturing: Unlocking Rapid, Off-the-Shelf Cancer Therapy
Liv Hospital Turkey Overview Allogeneic CAR-T cell manufacturing is poised to revolutionize cancer treatment by providing 'off-the-shelf' solutions derived from healthy donor cells. This approach dramatically shortens treatment timelines... -
Thermo Fisher Scientific Unveils Semi-Automated, Closed-Loop Workflow for Autologous CAR T Cell Manufacturing: A Leap in Consistency and Safety
Thermo Fisher Scientific USA Overview Thermo Fisher Scientific has introduced a new digitally compatible, semi-automated, closed, and GMP-compliant workflow platform designed to streamline autologous CAR T cell manufacturing. Integrating... -
ProBio Opens $25 Million Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, Creating Over 100 Highly Skilled Jobs
New Jersey Business Magazine USA Overview ProBio has inaugurated a $25 million, 128,000-square-foot Plasmid & Viral Vector Center of Excellence in Hopewell, New Jersey, significantly bolstering its production capabilities for cell an... -
EU-Funded S.O.L.A.R.I.S. Project Launched to Enhance Scalability, Efficiency, and Sustainability of CAR T Cell Manufacturing Across Europe
Green Elephant Biotech Germany Overview The EU-funded S.O.L.A.R.I.S. Project has commenced with 13 partners, including Green Elephant Biotech and Miltenyi Biotec, aiming to develop and implement new approaches for scalable, efficient, an... -
Roche Leverages NVIDIA AI Digital Twins for GLP-1 Biomanufacturing Innovation, Targeting 25-40% Capacity Increase and 15-20% Lead Time Reduction
IntuitionLabs Switzerland Overview Roche announced the integration of NVIDIA's AI and digital twin technologies, including BioNeMo, to optimize its biomanufacturing processes for GLP-1 pharmaceuticals. This initiative aims to create virt... -
Creative Life Science Unveils PIC/S GMP-Compliant Cell Therapy Platform at BIO Asia-Taiwan 2026, Bolstered by New Taiwan Regenerative Medicine Laws
PR Newswire Taiwan Overview According to PR Newswire, Creative Life Science is showcasing its PIC/S GMP-compliant cell therapy materials and manufacturing platform at BIO Asia-Taiwan 2026. The company's Zhubei biomanufacturing facility s... -
Celltrion Plans $503M Investment in US Biopharma Manufacturing Facility, Driving Biosimilars Market Expansion
Data Bridge Market Research India Overview This article provides an overview of a market research report published by Data Bridge Market Research. According to the Data Bridge Market Research report, the biosimilars manufacturing market ... -
Japan Prioritizes Quality in ‘China Plus One’ CDMO Strategy with Over $4 Billion Investment by FUJIFILM Diosynth and Others
BioProcess International USA Overview A BioProcess International article analyzes the 'China Plus One' strategy and biomanufacturing capacity in the APAC region. FUJIFILM Diosynth Biotechnologies has committed over $4 billion to global e... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ... -
Europe’s Biomanufacturing Blueprint: Leading the Next Industrial Race with Precision Fermentation
Science|Business Belgium / Europe Overview Europe is strategically positioned to spearhead the next industrial revolution in sustainable biomanufacturing through precision fermentation. This advanced biotechnology offers a path to enviro...
